4251 - 4260 of 4301 Drugs
Valstar (valrubicin)
Valstar (valrubicin) is a cancer (antineoplastic) medication used to treat bladder cancer.
Vancomycin Hydrochloride (vancomycin hydrochloride injection)
Vancomycin is an antibiotic indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci. Vancomycin is indicated for penicillin-allergic patients, for patients who cannot receive or who have failed to respond to other drugs, including the penicillins or cephalosporins, and for infections caused by Vancomycin susceptible organisms that are resistant to other antimicrobial drugs.
Varivax (varicella virus vaccine live)
Varivax (varicella virus vaccine live) is a live vaccine used to help prevent varicella virus infection (commonly known as chickenpox). Chickenpox is a common childhood illness, but can cause more serious illnesses in people who have not yet had either chickenpox or this vaccine.
Vasostrict (vasopressin injection)
Vasostrict (vasopressin injection) is a man-made form of a hormone called "anti-diuretic hormone" that is normally secreted by the pituitary gland used to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines.
Vecuronium Bromide (vecuronium bromide injection, powder, lyophilized, for solution)
Vecuronium bromide for injection is a nondepolarizing neuromuscular blocking agent indicated as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Vecuronium bromide is available in generic form.
VPRIV (velaglucerase alfa for injection)
VPRIV (velaglucerase alfa) is an enzyme produced in a fibroblast cell line that catalyzes the hydrolysis of the glycolipid glucocerebroside to glucose and ceramide in the lysosome of macrophage cell types. VPRIV is indicated for long-term enzyme replacement therapy for pediatric and adult patients with the rare genetic disorder, type 1 Gaucher disease.
Zelboraf (vemurafenib)
Zelboraf (vemurafenib) is a kinase inhibitor used to treat patients with metastatic melanoma with BRAFV600E mutation that is unable to be removed by surgery.
Venbysi XR (venlafaxine extended-release tablets)
Venbysi XR (venlafaxine extended-release tablets) is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated in adults for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD).